Overview

Benefits of Glycopyrrolate on Intubation With Rigid-videostylet (OptiScope®)

Status:
Completed
Trial end date:
2017-05-19
Target enrollment:
0
Participant gender:
All
Summary
This study is intended to evaluate the efficacy and safety of glycopyrrolate as an antisialagogue prior to intubation with the rigid-videostylet(Optiscope®) in the general anesthesia settings. Upper airway secretions limit the use of the videostylet during during endotracheal intubation. Therefore, in this study, patients will be allocated to either of the two groups according to the administration of glycopyrrolate and the effect of glycopyrrolate in reducing oral secretions will be assessed by the observer while intubating with the rigid-videostylet. The efficacy of the antisialagogic effect on the view during endotracheal intubation will be evaluated.
Phase:
N/A
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Eunah Cho, MD
Treatments:
Glycopyrrolate
Criteria
Inclusion Criteria:

- Patients undergoing elective laparoscopic cholecystectomy under general anesthesia

- aged from 19 to 65, adult patients

- american society of anesthesiologist physical status 1,2

- obtaining written informed consent

Exclusion Criteria:

- obese patients with body mass index above 30

- expected difficult intubation (ex. intraoral mass, history of former difficult
intubation, limitation of mouth opening..)